Author

Laraibah Hamid

Institution: University of Kashmir

Observed institution: University of Kashmir

ORCID: 0000-0002-2185-5927

Observed ORCID: 0000-0002-2185-5927

OpenAlex ID: A5061905974

Flavonoids as promising molecules in the cancer therapy: An insight

2023 · Suhail Ahmad Mir, Ashraf Dar, et al. · Current Research in Pharmacology and Drug Discovery · 167

Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review

2022 · Suhail Ahmad Mir, Laraibah Hamid, et al. · Molecules · 75

Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer

2023 · Suhail Ahmad Mir, Ashraf Dar, et al. · Pharmaceuticals · 48

An Insight into the Global Problem of Gastrointestinal Helminth Infections amongst Livestock: Does Nanotechnology Provide an Alternative?

2023 · Laraibah Hamid, Abdulrhman Alsayari, et al. · Agriculture · 42

Naringenin Inhibits Cellular Proliferation, Arrests Cell Cycle and Induces Pro‐Apoptotic Autophagy in MCF ‐7 Breast Cancer Cells

2025 · Suhail Ahmad Mir, Basharat Ahmad Bhat, et al. · Journal of Cellular and Molecular Medicine · 14

Integrating in-silico and experimental validation approaches to unveil the therapeutic mechanism of naringenin against breast cancer

2025 · Suhail Ahmad Mir, Basharat Ahmad Bhat, et al. · Scientific Reports · 8

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial

2022 · Suhail Ahmad Mir, Rifat Ara, et al. · Medicina · 7

Phytochemical profiling and anthelmintic potential of rhizome of Swertia petiolata against Haemonchus contortus: an integrated in vitro and in silico approach

2026 · Laraibah Hamid, Hidayatullah Tak, et al. · Veterinary Parasitology

Endometrial and placental dysfunction in recurrent pregnancy loss

2025 · Laraibah Hamid, Suhail Ahmad Mir, et al. · Elsevier eBooks

Works count: 10

Citation count: 361

H-index: 7

I10-index: 5